MFG
CL icon

Merit Financial Group’s Colgate-Palmolive CL Stock Holding History

Merit Financial Group’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.67M Buy
50,926
+2,700
+6% +$236K 0.03% 455
2026
Q1 		$4.11M Buy
48,226
+4,429
+10% +$395K 0.03% 446
2025
Q4 		$3.46M Buy
43,797
+10,007
+30% +$785K 0.03% 459
2025
Q3 		$2.7M Sell
33,790
-506
-1% -$43.2K 0.02% 471
2025
Q2 		$3.12M Sell
34,296
-513
-1% -$46.8K 0.03% 389
2025
Q1 		$3.26M Buy
34,809
+4,169
+14% +$373K 0.05% 301
2024
Q4 		$2.79M Buy
30,640
+8,114
+36% +$774K 0.05% 292
2024
Q3 		$2.34M Sell
22,526
-1,886
-8% -$192K 0.05% 253
2024
Q2 		$2.37M Buy
24,412
+12,695
+108% +$1.17M 0.05% 248
2024
Q1 		$1.09M Buy
11,717
+2,588
+28% +$219K 0.03% 381
2023
Q4 		$728K Buy
9,129
+825
+10% +$62K 0.02% 393
2023
Q3 		$591K Buy
8,304
+249
+3% +$18.6K 0.02% 420
2023
Q2 		$621K Buy
8,055
+281
+4% +$21.8K 0.02% 420
2023
Q1 		$584K Sell
7,774
-215
-3% -$16K 0.02% 367
2022
Q4 		$629K Buy
7,989
+966
+14% +$72.4K 0.02% 377
2022
Q3 		$493K Buy
7,023
+216
+3% +$16.9K 0.02% 360
2022
Q2 		$546K Buy
6,807
+265
+4% +$20.7K 0.02% 342
2022
Q1 		$496K Sell
6,542
-7,879
-55% -$624K 0.03% 237
2021
Q4 		$1.23M Sell
14,421
-50
-0.3% -$3.9K 0.12% 83
2021
Q3 		$1.09M Buy
14,471
+107
+0.7% +$8.5K 0.11% 91
2021
Q2 		$1.17M Buy
14,364
+328
+2% +$26.8K 0.11% 88
2021
Q1 		$1.11M Buy
14,036
+443
+3% +$34.7K 0.12% 89
2020
Q4 		$1.16M Buy
13,593
+1
+0% +$83 0.11% 77
2020
Q3 		$1.05M Buy
13,592
+535
+4% +$40.8K 0.1% 85
2020
Q2 		$957K Sell
13,057
-244
-2% -$17.3K 0.1% 85
2020
Q1 		$883K Buy
13,301
+326
+3% +$23K 0.1% 84
2019
Q4 		$893K Buy
12,975
+6,430
+98% +$438K 0.08% 93
2019
Q3 		$481K Buy
6,545
+171
+3% +$12.4K 0.05% 87
2019
Q2 		$456K Buy
6,374
+203
+3% +$14.4K 0.05% 69
2019
Q1 		$422K Buy
6,171
+1,063
+21% +$68.7K 0.05% 69
2018
Q4 		$304K Buy
5,108
+105
+2% +$6.57K 0.05% 84
2018
Q3 		$334K Sell
5,003
-138
-3% -$9.19K 0.05% 87
2018
Q2 		$333K Buy
5,141
+279
+6% +$18.3K 0.06% 82
2018
Q1 		$348K Buy
4,862
+458
+10% +$33K 0.07% 66
2017
Q4 		$332K Buy
+4,404
New +$322K 0.07% 80

Other funds holding CL

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Merit Financial Group's CL Position: Q2 2026 in Review

Merit Financial Group increased its Colgate-Palmolive (CL) stake by 5.6% in Q2 2026, buying an estimated $236K and bringing the position to 50,926 shares worth $4.67M. The position accounts for 0.03% of the portfolio, ranked #455.

Merit Financial Group first reported a position in CL in Q4 2017 and has held it in 35 quarters since. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Merit Financial Group held 50,926 shares of Colgate-Palmolive worth $4.67M as of Q2 2026.
  • Merit Financial Group bought 2,700 Colgate-Palmolive shares in Q2 2026, an estimated $236K.
  • Colgate-Palmolive made up 0.03% of Merit Financial Group's portfolio in Q2 2026, its #455 holding.
  • Merit Financial Group first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 35 quarters since.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.